ArticleBMC pulmonary medicine2023
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with NTRK family mutations.
Xiaoling Shang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it